Did Vitamin D, Omega-3 Supplements Help Prevent Development, Progression of CKD in Adults With Type 2 Diabetes?

JAMA

EMBARGOED FOR RELEASE: 2 P.M. (ET), FRIDAY, NOVEMBER 8, 2019

Media advisory: The full study and editorial are linked to this news release. This study is being released to coincide with presentation at Kidney Week 2019.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.17380?guestAccessKey=52eec612-76c3-4d08-8c0b-496acbf71159&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110819

 

What The Study Did: Researchers in this randomized clinical trial investigated if supplementation with vitamin D or omega-3 fatty acids compared with placebo over five years helped prevent the development or progression of chronic kidney disease among adults with type 2 diabetes. The main outcome measure was change in the glomerular filtration rate that was estimated from serum creatinine and cystatin C.

Authors: Ian H. de Boer, M.D., M.S., of the University of Washington in Seattle, is the corresponding author.

 

(doi:10.1001/jama.2019.17380)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.